Merck to manufacture NewLink Ebola vaccine in-house
Merck has agreed to research, develop, manufacture, and distribute NewLink’s investigational Ebola vaccine candidate, which is currently in Phase I trials.
Archives for November 25, 2014
UPDATE
AstraZeneca injects $200m into Maryland plant to support biologics pipeline
AstraZeneca is investing over $200m (€160m) at a facility in Maryland to support its pipeline of over 120 biologics, the company says.
AbbVie buys small molecule API plant to support ADC manufacture in Singapore
An API facility in Singapore acquired by AbbVie on the site where it is building a $320m biologics plant will support the firm's antibody-drug conjugate (ADC) pipeline.